Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RSV oral vaccine (PlantPharm BioMed)
- Development stage
- Preclinical
- Lead developer
- PlantPharm BioMed
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Administration
- Oral
01
Overview
RSV oral vaccine (PlantPharm BioMed) is a plant-based vaccine candidate currently in preclinical development for the prevention of Respiratory Syncytial Virus (RSV) infection. Developed using PlantPharm BioMed's proprietary platform, the vaccine involves expressing RSV-specific antigens within plant tissues, which are then processed into an oral solid dose formulation. This technology is designed to leverage the plant cell wall to protect the antigens through the stomach, allowing for delivery to the gut-associated lymphoid tissue (GALT) to stimulate both mucosal and systemic immunity. This oral delivery method aims to provide a more convenient, stable, and potentially more effective alternative to traditional injectable vaccines for RSV.
- Other names
- RSV vaccineoral solid dose RSV vaccineplant-based RSV vaccine
Beyond the preview
Go deeper on RSV oral vaccine (PlantPharm BioMed).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RSV oral vaccine (PlantPharm BioMed).